Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

This new color is part of a bigger push to phase out artificial dyes, which have raised concerns in recent years.

HealthDay News — Approved label populations for new drugs are broader than trial populations overall, according to a study published online July 8 in the Annals of Internal Medicine.

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder.

The CUP-DIU study explored the relationship between IUD displacement and the use of a menstrual cup in 747 women who consulted for follow-up of their IUD at 2 primary care facilities in Paris.

Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...

OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

The Food and Drug Administration (FDA) has accepted the supplemental New Drug Application (sNDA) for decitabine/cedazuridine plus venetoclax to treat adults with newly diagnosed acute myeloid leukemia ...

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.

Pneumonic plague is often transmitted by fleas that have bitten infected rodents. The fleas can also infect pets or humans.